₦90K
Weekly Giveaway — 5 Winners Every Week
1st: ₦50K | 2nd–5th: ₦10K each | Be active to win
pharmaceuticals
-
O
Why May & Baker Is Emerging as a Quiet Healthcare Winner in 2026
Why May & Baker Is Emerging as a Quiet Healthcare Winner in 2026 With the Nigerian Exchange (NGX) already up 4.9% in early 2026 and market capitalisation holding firmly above ₦100 trillion, investor optimism is proving stronger than many expected. Several stocks previously identified for upside...- Olori Uwem
- Thread
- may&baker pharmaceuticals
- Replies: 0
- Forum: Nigeria Stock Exchange
-
O
PHARMACEUTICAL COMPANIES CUT PROFIT TO REDUCE DRUG PRICES – FIRM
PHARMACEUTICAL COMPANIES CUT PROFIT TO REDUCE DRUG PRICES – FIRM The article discusses how pharmaceutical companies in Nigeria, including May & Baker Nigeria Plc, have been cutting their profits to help make drugs more affordable amid rising prices. 1. Key Points: a. Efforts to Make Drugs...- Olori Uwem
- Thread
- drugprice pharmaceuticals
- Replies: 0
- Forum: Nigeria Stock Exchange
-
O
NEIMETH REPORTS 144% PROFIT SURGE IN H1 2024
NEIMETH REPORTS 144% PROFIT SURGE IN H1 2024 SUMMARY: Neimeth International Pharmaceuticals Plc has reported a significant increase in its post-tax profit for the first half of 2024, reaching N198.2 million—a 144% rise from the previous year. This growth is attributed to improved production...- Olori Uwem
- Thread
- earnings report financials neimeth international pharmaceuticals plc pharmaceuticals profit
- Replies: 0
- Forum: Nigeria Stock Exchange
-
O
NEIMETH PHARMACEUTICALS FINANCIAL PROJECTIONS AND STRATEGIC PLANS
NEIMETH PHARMACEUTICALS FINANCIAL PROJECTIONS AND STRATEGIC PLANS 1. Profit Projection: - Neimeth Pharmaceuticals Plc is projecting a profit of N211 million for the 2024 financial year. 2. Revenue and Growth Plans: - The company aims to achieve N5 billion in revenue for 2024. - There...- Olori Uwem
- Thread
- earningsforecast health neimethpharmaceuticals pharmaceuticals revenue stocks
- Replies: 0
- Forum: Nigeria Stock Exchange